News
Tesla’s health clinic surgeon explains practice amid Reveal’s new allegations
Last Monday, an expose was published accusing Tesla of intentionally ignoring workers’ injuries. Citing former employees and a physician assistant who briefly worked in the company’s health clinic at the Fremont factory, Reveal, a publication that prides itself with its investigative reporting, accused Tesla of withholding medical care to its workers, to minimize how many injuries the company includes in its official records.
The new expose is not the first time Reveal trained its sights on the electric car maker. Earlier this year, the publication, based on accounts from former employees, accused Tesla of misreporting injury rates and ignoring safety concerns due to the whims of executives like Elon Musk. The publication’s allegations ultimately resulted in an investigation by the CAL-OSHA, which lasted four months. As noted by VP for Environmental, Health and Safety (EHS) Laurie Shelby during the third quarter earnings call and in a following blog post in Tesla’s official website, the CAL-OSHA investigation found no misreporting on Tesla’s part. The CAL-OSHA did find one safety issue and one record-keeping error during its four month-long investigation, in the form of an extension cord that was categorized as a trip hazard and an injury log that had an incorrect date.
Apart from doubling down on previous allegations — such as Tesla’s factories lacking hazard signs due to Elon Musk’s dislike of the color yellow — Reveal‘s new expose, written by journalist Will Evans, related several accounts of workers being denied proper medical care. One such instance involved a worker who severed the top of a finger being sent to the emergency room in a Lyft, as well as an employee who was asked to report to work even after being injured in the Model X line. The publication also alleged that Tesla forbids employees to call 911 without a doctor’s permission. Former PA Anna Watson, who worked in Tesla’s Fremont health clinic for about three weeks, noted that Tesla’s employees are paying the price for the company’s unsafe practices. Watson further alleged that she was terminated by Access Omnicare after raising safety concerns.
“The goal of the clinic was to keep as many patients off of the books as possible. The way they were implementing it was very out of control. Every company that I’ve worked at is motivated to keep things not recordable. But I’ve never seen anybody do it at the expense of treating the patient,” she said.
The publication’s new allegations have emerged as a dark cloud hovering over Tesla’s revamped workers’ safety programs, which have been at the forefront of the company as it continues to ramp its operations. Since hiring VP for Environmental, Health and Safety (EHS) Laurie Shelby last year, Tesla has actively rolled out new initiatives to raise the level of safety for its facilities’ amidst the company’s ever-increasing number of workers. Shelby, for one, has noted that Tesla remains focused on its efforts to become the safest car factory in the world.
Tesla is yet to respond to Reveal‘s new report, though a spokesperson from the company noted that Watson completed a total of five shifts before her employment was terminated. Dr. Basil Besh, an orthopedic surgeon and founder of Access Omnicare, has also issued a statement explaining the company’s practices when dealing with workers’ injuries. Besh, who currently serves as the chair of the American Academy of Orthopaedic Surgeons (AAOS) Board of Councilors (BOC), noted that the care that Access Omnicare gives to Tesla’s employees is the same care he gives to his personal clientele. The orthopedic surgeon noted that he had spoken to Reveal journalist Will Evans about the safety practices in the Fremont factory.
“I spent nearly one hour with Reveal detailing Tesla’s decision earlier this year to bring me and my medical team on site at Fremont, providing its employees with state-of-the-art occupational and musculoskeletal health care. I detailed our vision for exemplary patient care, and I gave specific examples of protocol improvements and subsequent successes in outcomes in only four short months, including accurate diagnoses and reducing needless delays for advanced testing and treatment. I patiently educated Will Evans on how Tesla allowed me to give the same care to Tesla employees that I do to my private patients including ones who are professional athletes, with the ability to get necessary testing and treatment in a timely manner without being hindered by an often cumbersome California Worker’s Compensation System that sometimes negatively effects injured workers.”
Dr. Besh further noted that different types of injuries require different types of immediate care. The medical professional also denies that any malpractice is ongoing in the Tesla factory.
“I counseled Will on the difference between subjective complaints of pain, which cannot be proven and are often magnified, and objective signs found only on careful clinical examination by an experienced physician. I even mailed Will a copy of a relevant chapter from the American Medical Association Return to Work Guidelines and offered to make myself available for additional questions. Research and evidence-based medicine indicate that deconditioning injuries involving sore muscles should not be treated with inactivity as this only exacerbates the problem, but should instead be treated by proactive conditioning, ergonomic modifications, and supportive care. Not all patients in pain should be off work, at home, and on opioids. In fact, it is most often in these patients’ best interest to have supportive care that enhances their activity, their function, and their well-being.
“As a physician, my foremost obligation is to perform a careful history and physical examination, order additional tests when clinically indicated, make an accurate diagnosis, and deliver the absolute best care possible. If patients are injured, and continued work presents safety issues for the patient, myself and my fellow physicians prescribe the appropriate work restrictions. Any suggestion that myself or any of my medical team at AOC allow external factors to influence our medical care in any way is false and inaccurate.”
Ultimately, Dr. Besh also pointed out that ambulances are reserved for life or limb-threatening injuries. The surgeon did not provide a direct comment about former physician assistant Anna Watson, due to the latter being the subject of an ongoing investigation by the California Medical Board.
“Rather than deliver an informative and balanced piece of journalism, Reveal has instead chosen to hitch its wagon to Ms. Anna Watson, a provider with whom we severed ties after less than two weeks at our clinic and about whom I cannot provide any additional comment as she is currently the subject of an investigation by the California Medical Board. Instead of highlighting the tremendous progress being made in both patient safety and patient care at Tesla, this report uses poor sourcing to tell a story consistent with a predetermined agenda,” Dr. Besh stated.
Tesla’s Cybercab has taken a significant step toward production with new technical details emerging from 2026 EPA certification documents.
The filings, which include a Certificate of Conformity issued in late May, provide the most comprehensive public look yet at the purpose-built autonomous vehicle designed for high-volume, low-cost ride-hailing operations.
At its core, the Cybercab is a front-wheel-drive electric vehicle powered by a single 163 kW (219 horsepower) AC permanent magnet motor. Despite its modest output, prioritizing efficiency and cost over neck-snapping acceleration, the vehicle boasts a strong power-to-weight ratio thanks to its lightweight curb weight of 3,113 pounds and a GVWR of 3,730 pounds.
It operates on a 326-volt electrical architecture with a compact ~48 kWh lithium-ion battery pack. The standout revelation is the vehicle’s exceptional efficiency, which Tesla has routinely flexed in the past.
EPA lab tests list an equivalent all-electric range of 418 miles combined and 375 miles on the highway. Tesla has previously targeted around 300 miles of real-world range, and analysts expect the final EPA-rated figure to land near 280-300 miles after adjustment factors.
At a certified 165 Wh/mi in earlier testing, the Cybercab is reportedly the most efficient EV ever produced, significantly outperforming vehicles like the Lucid Air Pure.
New information about @Tesla‘s Cybercab has been revealed in public EPA documents.
• Front-wheel drive
• Battery capacity: ~48 kWh
• 219 horsepower
• Curb weight: 3,113 lbs
• GVWR: 3,730 lbs
• Motor power: 163kW
• Voltage: 326vEquivalent All Electric Range is listed at… pic.twitter.com/D4gkJJTj25
— Sawyer Merritt (@SawyerMerritt) June 15, 2026
This efficiency stems from deliberate design choices tailored for robotaxi duty. The two-seater features a highly aerodynamic shape, minimal weight, which is aided by structural battery integration of what are likely 4680 cells, and no steering wheel or pedals in its fully autonomous configuration.
For ride-hailing fleets, where average trips are short, and can be just five or ten miles, the smaller battery enables faster charging cycles, lower material costs, and reduced vehicle price, a key to Tesla’s goal of a ~$30,000 production cost.
Implications for Autonomous Mobility
These specs underscore Tesla’s strategy: maximize utilization and minimize operating expenses. A ~48 kWh pack could support dozens of short rides per charge, with energy costs potentially dropping below 20 cents per mile at scale. Front-wheel drive simplifies manufacturing and maintenance compared to dual-motor AWD setups in passenger Teslas.
The 219 hp motor provides ample performance for urban and highway speeds without excess, addressing questions about why such power is needed in a “slow” autonomous vehicle. Quick merges and hill climbing still matter for safety and passenger comfort.
Production has already begun at Giga Texas, with EPA certification clearing the path for U.S. deployment. While unsupervised Full Self-Driving remains the critical hurdle, these details paint a compelling picture of a vehicle engineered from the ground up for the robotaxi future: affordable to build, cheap to run, and capable of delivering strong range on a fraction of the battery capacity found in today’s EVs.
As Tesla ramps toward volume output, the Cybercab could reshape urban transportation economics.
Tesla Cybercab, the all-electric ride-hailing-geared vehicle void of a steering wheel and pedals, has achieved a significant regulatory milestone. The vehicle has officially secured an EPA Certificate of Conformity for the 2026 Cybercab, classifying it as a battery electric Zero Emission Vehicle (ZEV).
This certification confirms full compliance with federal Clean Air Act emission standards, paving the way for legal sales and operation across the United States.
A Certificate of Conformity (CoC) is a critical document issued by the U.S. Environmental Protection Agency (EPA) to vehicle manufacturers. It certifies that a specific class of vehicles meets all applicable federal emission requirements for the model year.
We have reported on several of them in the past, and it’s a good sign that a vehicle is close to being available to the public.
Every vehicle sold in the U.S. must carry this approval, which covers exhaust emissions, evaporative emissions, and refueling standards. For battery electric vehicles like the Cybercab, it verifies zero tailpipe emissions and compliance with stringent testing protocols. The certificate, issued and effective May 26, 2026, was part of the EPA’s recent bi-weekly upload, detailing the Cybercab’s evaporative/refueling family and exhaust compliance.
It also revealed some other very important information, as the Cybercab’s “Charge Depleting Range” was rated at just over 418 miles. This was for city driving, while the highway range depletion test revealed just over 375 miles of range:
Highway miles for Charge Depleting Range was just over 375 miles
— TESLARATI (@Teslarati) June 15, 2026
This EPA approval is a foundational step for Tesla’s autonomous ambitions. While emission certification is standard for any new EV, it signals that the Cybercab is progressing through the full federal compliance process.
Tesla has already equipped prototypes with federal compliance stickers affirming adherence to safety, bumper, and theft-prevention standards via self-certification under FMVSS rules. This bypasses the traditional 2,500-vehicle exemption cap that previously constrained low-volume autonomous testing.
Production of the Cybercab ramped up at Giga Texas starting in early 2026, with volume targets aiming for hundreds of units per week and long-term ambitions of millions annually. The two-seater, steer-by-wire vehicle, lacking a steering wheel and pedals, features a sleek, minimalist design optimized for Robotaxi service.
Priced under $30,000 at unveiling, it promises operating costs as low as $0.20–$0.40 per mile once scaled. Tesla has routinely flexed it as one of the most efficient vehicles of all time.
Regulatory progress extends beyond the EPA. The NHTSA has streamlined approvals for control-free vehicles, benefiting the Cybercab. Tesla operates supervised and unsupervised Robotaxi services in Texas cities like Austin, Dallas, and Houston using its fleet. California recently updated rules for driverless operations, including enforcement mechanisms for violations. Additional state-by-state approvals will be needed for nationwide rollout.
This EPA green light reduces a key barrier, building confidence among regulators, partners, and investors.
It underscores Tesla’s strategy of designing the Cybercab from the ground up for full compliance rather than retrofitting existing platforms. Challenges remain in scaling unsupervised autonomy, mapping approvals, and public acceptance, but the certification marks tangible momentum toward transforming urban mobility.
With prototypes already testing on public roads and production accelerating, the Cybercab edges closer to redefining transportation. Tesla’s integrated approach—combining hardware simplicity, software prowess, and regulatory diligence—positions it uniquely in the robotaxi race.
SpaceX executed its first Falcon 9 launch since going public on June 15, a routine yet symbolically powerful Starlink mission from Vandenberg Space Force Base in California.
Liftoff of the Falcon 9 booster B1093, on its 14th flight, occurred at approximately 8:34 a.m. PDT from Space Launch Complex 4E (SLC-4E), deploying 24 Starlink V2 Mini Optimized satellites into low-Earth orbit.
The first stage successfully landed on the droneship “Of Course I Still Love You” in the Pacific Ocean, underscoring the company’s unmatched reusability track record.
Watch Falcon 9 launch 24 @Starlink satellites to orbit from California https://t.co/meDwb05qOE
— SpaceX (@SpaceX) June 15, 2026
This mission comes just three days after SpaceX’s historic IPO on June 12, which shattered records as the largest ever. The company raised $75 billion by pricing shares at $135, with trading under ticker SPCX on Nasdaq opening at $150 and closing at $160.95—a 19 percent gain—valuing SpaceX at over $2.1 trillion.
The launch highlights the seamless transition from private innovator to public powerhouse. SpaceX, founded in 2002, has revolutionized access to space with over 650 Falcon 9 flights and a massive Starlink constellation now serving millions globally.
As a public company, it faces new pressures: quarterly earnings, shareholder scrutiny, and expectations to accelerate Starship development for Mars ambitions and deeper NASA partnerships. Yet the market response signals strong confidence in its dominance, as launch costs are slashed by 95 percent, rapid satellite deployment, and a backlog of government and commercial contracts.
SpaceX maintains bold advertising push for Starlink, contrasting Tesla’s minimalistic approach
Analysts view today’s flight as business as usual, but it carries extra weight. With shares volatile in early trading days, successful operations reassure investors that core capabilities remain unaffected by public status.
SpaceX now operates under heightened transparency, potentially unlocking capital for ambitious goals like Starship orbital tests and global broadband expansion.
Challenges loom, including regulatory hurdles for megaconstellations, competition in reusable rockets, and orbital debris concerns. Nevertheless, this morning’s flawless execution reinforces SpaceX’s trajectory.
As Musk often notes, the company’s mission—to make humanity multiplanetary—now aligns with Wall Street’s growth demands. The stars, it seems, are aligning for both.
Tesla Cybercab specs revealed: range, curb weight, range ratings, and more
Tesla Cybercab snags huge regulatory green light that readies it for public roads
